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Schizophrenia  is  a  complex  disorder  affecting  approximately  1%  of  the  population. 
Typical  antipsychotic  agents such as chlorpromazine and haloperidol  block the D2 subtype  of 
dopamine receptors in a direct relation to their clinical potency. However, although blockade of 
D2 receptors improves the positive symptoms of the disease, it also accounts for side effects which 
strongly limit patient compliance, in particular extrapyramidal effects and hyperprolactinemia.
During  the  past  few  years,  a  second  generation  of  antipsychotic  agents  has  emerged 
(e.g.,clozapine,  risperidone,  olanzapine,  and  ziprasidone);  they  are  categorized  as  atypical  in 
contrast to conventional D2 blockers and exhibit a dual dopaminergic and serotonergic mechanism 
of action: a relatively weak dopamine D2 receptor antagonism in vitro and in vivo, but potentially 
important  activities  at  other  dopaminergic  (D1,  D4)  receptors,  at  serotonergic  (5-HT1A,  5HT2A, 
5HT3, 5HT2C), adrenergic (α1, α2), histaminergic (H1), and muscarinic receptors. They are claimed 
to be active against both positive and negative symptoms of schizophrenia, even though they do 
exhibit a variety of other side effects as weight gain, postural hypotension, sedation, dry mouth. 
For these reasons the search for more effective and less toxic agents still continues [1,2].
In  this  context  we  have  developed  a  series  of  (1,2-diphenyl-imidazolyl)piperazine 
derivatives (1) that are endowed with substantial affinities for both dopamine D2 receptors as well 




We have extended our study on other series of compounds derived from 1 both modifying 
the 1,2-diphenyl motif attached to the imidazole core, and the phenyl-piperazine moiety.
All  novel  compounds  were  submitted  by  Lundbeck  to  radioligand  binding  assay  on 
dopamine, serotonin, adrenergic, histaminergic receptor subtypes. The chemistry and the in vitro 
screening will be discussed in the poster.
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